08 September 2003
Characterization of Helicobacter pylori strains isolated before and after therapy
Ewa Andrzejewska, Andrzej Szkaradkiewicz, Henryk Klincewicz, Krzysztof LinkeMed Sci Monit 2003; 9(9): CR400-404 :: ID: 13192
Abstract
Background:Genotypic analysis has been performed in Helicobacter pylori strains isolated before and after antibiotic therapy from patients for whom no eradication of the microbes could be achieved.Material/Methods:The Helicobacter pylori strains were isolated from 10 patients with duodenal ulcer, who were treated by the triple therapy (Controloc with amoxicillin and metronidazole). Biopsies of gastric mucosa were inoculated on the Columbia agar with antibiotics and on the medium without antibiotics. The cultures were kept in microaerophilic conditions at 37°C for 4 to 10 days. Genotype analysis was performed using PCR-based RAPD fingerprinting. The sensitivity of the strains to metronidazole, clarithromycin, amoxicillin and tetracycline was tested using E-tests.Results:In five patients, identical strains of the bacteria were noted both before and after the therapy while distinct patterns of pre- and post-treatment isolates were found in three patients. One patient demonstrated identical strains before and after the therapy but upon later control testing was found to be infected with a genotypically distinct strain. In 2 patients (a married couple) the infection was caused by genotypically distinct strains. A high proportion (46%) of metronidazole-resistant strains was detected.Conclusions:Therapeutic failures in treatment of Helicobacter pylori infections may either be the result of ineffective eradication of the strain from the stomach or of a re-infection. When applying treatment with antibiotics, high frequency of metronidazole resistance should be taken into account.
Keywords: Anti-Bacterial Agents, DNA Fingerprinting, DNA, Bacterial - analysis, Drug Resistance, Bacterial, Drug Therapy, Combination - pharmacology, Drug Therapy, Combination - therapeutic use, Duodenal Ulcer - drug therapy, Duodenal Ulcer - microbiology, Helicobacter Infections - drug therapy, Helicobacter Infections - microbiology, Helicobacter pylori - drug effects, Helicobacter pylori - genetics, Helicobacter pylori - isolation & purification, Microbial Sensitivity Tests, Random Amplified Polymorphic DNA Technique
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
15 Mar 2024 : Clinical Research
Impact of One-Lung Ventilation on Oxygenation and Ventilation Time in Thoracoscopic Heart Surgery: A Compar...Med Sci Monit In Press; DOI: 10.12659/MSM.943089
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952